logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

MICROTECH MED-B (02235) spent 261,900 Hong Kong dollars to repurchase 38,600 shares on November 24th.

date
21:44 24/11/2025
avatar
GMT Eight
"Vitale Medical -B (02235) announces that on November 24, 2025, the company allocated funds of 26.19 million..."
MICROTECH MED-B (02235) announced on November 24, 2025 that the company will spend 261,900 Hong Kong dollars to repurchase 38,600 shares at a repurchase price of 6.52-6.88 Hong Kong dollars per share.
Related Articles
US Stock Market Move | Q3 earnings per share significantly increased, Qudian, Inc. Sponsored ADR Class A (QD.US) rose over 6% in early trading.
HK Stock
XJ INTL HLDGS(01765) expects annual net profit to be approximately 3.66 billion to 4.16 billion yuan.
HK Stock
DRCB (09889) recommends appointing Chen Guofeng as an independent non-executive director.
US Stock Market Move | Q3 earnings per share significantly increased, Qudian, Inc. Sponsored ADR Class A (QD.US) rose over 6% in early trading.
XJ INTL HLDGS(01765) expects annual net profit to be approximately 3.66 billion to 4.16 billion yuan.
HK Stock
DRCB (09889) recommends appointing Chen Guofeng as an independent non-executive director.
HK Stock
RECOMMEND
Dutch Government Suspends Ban; Wingtech Has Not Fully Regained Control Of Nexperia
Dutch Government Suspends Ban; Wingtech Has Not Fully Regained Control Of Nexperia
icon
20/11/2025
Nearly HKD 200 Billion; Hong Kong Stocks Face A Year-End “Unlocking Frenzy” Test
Nearly HKD 200 Billion; Hong Kong Stocks Face A Year-End “Unlocking Frenzy” Test
icon
20/11/2025
Japanese Economist: Sharp Decline In Chinese Tourists Could Cost Japan Trillions Of Yen Annually
Japanese Economist: Sharp Decline In Chinese Tourists Could Cost Japan Trillions Of Yen Annually
icon
20/11/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.